US 9993450
Dosage forms and therapeutic uses of L-4-chlorokynurenine
granted A61KA61K31/198A61K9/0053
Quick answer
US patent 9993450 (Dosage forms and therapeutic uses of L-4-chlorokynurenine) held by VISTAGEN THERAPUETICS, INC. expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VISTAGEN THERAPUETICS, INC.
- Grant date
- Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/198, A61K9/0053, A61P, A61P25/14